Decreased circulating ghrelin levels influence the growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis, potentially leading to increased insulin resistance and the development of T2DM. However, studies have reported both reduced and elevated plasma ghrelin levels in diabetes, depending on the model and disease stage [12, 13]. This evidence concerns the gene GHRL and type 2 diabetes mellitus.